References
- 1. Hines R, Barash PG, Watrous G, O’Connor T. Complications occurring in the postanesthesia care unit: a survey. Anesth Analg 1992;74:503-9.10.1213/00000539-199204000-000061554116
- 2. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010;112:1013-22.10.1097/ALN.0b013e3181cded0720234315
- 3. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the Postanesthesia Care Unit. Anesth Analg 2008;107:130-7.10.1213/ane.0b013e31816d126818635478
- 4. Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP, Math M.Critical respiratory events in the postanesthesia care unit:patient, surgical, and anesthetic factors. Anesthesiology 1994;81:410-18.10.1097/00000542-199408000-000208053592
- 5. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, Gray J, Landry E, Gupta DK. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946-54.10.1097/ALN.0b013e318234284021946094
- 6. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on theincidence of critical respiratory events. A randomised,prospective, placebo-controlled trial. Eur J Anaesthesiol 2011;28:842-48.10.1097/EJA.0b013e328345cd1121455074
- 7. Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br. J. Anaesth 2006;97: 160-3.10.1093/bja/ael14216782976
- 8. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuroniuminduced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth. 2012;108:236-9.10.1093/bja/aer33022012861
- 9. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC:Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001;56:213-8.
- 10. McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology. 2011;114:318-29.10.1097/ALN.0b013e3182065c3621239968
- 11. Magnusson L, Spahn DR. New concepts of atelectasis during general anaesthesia. Br J Anaesth 2003;9:61-72. Anesth Analg. 2004;99:1086-9.
- 12. Arbous MS, Meursing AEE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE. Impact of anesthesia management characteristics on severemorbidity and mortality. Anesthesiology 2005;102:257- 68.10.1097/00000542-200502000-0000515681938
- 13. Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.Anesth Analg 2004;99:1086-9.10.1213/01.ANE.0000120081.99080.C215385355
- 14. Suy K, Morias K, Cammu G et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007;106:283-88.10.1097/00000542-200702000-0001617264722
- 15. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011;66:721-25. 10.1111/j.1365-2044.2011.06782.x21692760